Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2727.2000 13.10 (0.48%)
NSE Apr 21, 2025 15:54 PM
Volume: 65,170
 

2727.20
0.48%
Emkay
DLPL posted a robust quarter, with revenue growing 11% YoY on the back of
sample volume increasing 9% YoY and Swasthfit contributing 24% to the
topline.
Dr. Lal Pathlabs Ltd. has an average target of 2898.50 from 4 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended